Abstract
The aim of this paper was to critically review the current treatment of anxiety disorders including general anxiety disorder, panic disorder, social anxiety disorder and post-traumatic stress disorder. For all these disorders, this paper will suggest treatment guidelines based on literature data as well as personal experience. Obsessive compulsive disorder (OCD) even considered in DSM IV as an anxiety disorder is somewhere different from the other anxiety disorder (almost lack of placebo response, efficacy of cognitive- behavioural therapy and deep brain stimulation).
Keywords: Benzodiazepines, serotonin selective reuptake inhibitors (SSRIs), antidepressants, generalized anxiety disorder (GAD), panic disorder (PD), social anxiety disorder (SAD), post traumatic stress disorder (PTSD).
Current Psychopharmacology
Title:A Critical Approach of the Current Treatment of Anxiety Disorders
Volume: 2
Author(s): Michel Bourin and Florence Thibaut
Affiliation:
Keywords: Benzodiazepines, serotonin selective reuptake inhibitors (SSRIs), antidepressants, generalized anxiety disorder (GAD), panic disorder (PD), social anxiety disorder (SAD), post traumatic stress disorder (PTSD).
Abstract: The aim of this paper was to critically review the current treatment of anxiety disorders including general anxiety disorder, panic disorder, social anxiety disorder and post-traumatic stress disorder. For all these disorders, this paper will suggest treatment guidelines based on literature data as well as personal experience. Obsessive compulsive disorder (OCD) even considered in DSM IV as an anxiety disorder is somewhere different from the other anxiety disorder (almost lack of placebo response, efficacy of cognitive- behavioural therapy and deep brain stimulation).
Export Options
About this article
Cite this article as:
Bourin Michel and Thibaut Florence, A Critical Approach of the Current Treatment of Anxiety Disorders, Current Psychopharmacology 2013; 2 (2) . https://dx.doi.org/10.2174/2211556011302020002
DOI https://dx.doi.org/10.2174/2211556011302020002 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting MCP-1 to Reduce Vascular Complications of Obesity
Recent Patents on Cardiovascular Drug Discovery Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design HIV Protease Inhibitors: Peptidomimetic Drugs and Future Perspectives
Current Medicinal Chemistry Molecular Genetics and Epidemiology of Osteoporosis
Current Pharmacogenomics Peptide-Based Inhibitors of the HIV Envelope Protein and Other Class I Viral Fusion Proteins
Current Pharmaceutical Design Therapeutic Agents Based on DNA Sequence Specific Binding
Current Topics in Medicinal Chemistry Treatments for Obesity-Related Hypertension
Current Hypertension Reviews Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression
Current Molecular Medicine Anti-Cancer Therapy: Targeting the Mevalonate Pathway
Current Cancer Drug Targets Anti-Infectious Activity in the Cistaceae Family in the Iberian Peninsula
Mini-Reviews in Medicinal Chemistry Patent Selections
Recent Patents on DNA & Gene Sequences 25OH-Vitamin D3 Levels in Obesity and Metabolic Syndrome—Unaltered in Young and not Correlated to Carotid IMT in All Ages
Current Pharmaceutical Design Targeting Angiogenesis in Renal Cell Carcinoma
Current Cancer Drug Targets Complications of the Chest Wall and the Respiratory System After Surgery and Functional Performance
Current Respiratory Medicine Reviews Estrogen: Roles in Spermatogenesis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Clinical and Pre-clinical Applications of the Transcendental Meditation Program® in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults
Current Hypertension Reviews Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
Current Neuropharmacology The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
Current Medicinal Chemistry Tuberculosis Therapeutics: Past Achievements, Present Road-Blocks and Future Perspectives
Letters in Drug Design & Discovery Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?
Current Pharmaceutical Design